OKYO
NASDAQ
$1.37
OKYO Pharma Ltd - New (OKYO)
OKYO Pharma Limited, a preclinical biopharmaceutical company, is engaged in developing therapies for patients suffering from inflammatory eye diseases and eye pain in the UK. The company is headquartered in London, the United Kingdom.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $8.33 (+508.03%)
Market Cap
$56M
EPS 5Y CAGR
+375.62%
Free Cash Flow Yield
-12.97%
Beta (5Y)
0.84
Price Chart
Valuation
Market Cap$56M
P/B14.11
Profitability
Gross Profit (TTM)-$8.41M
EBITDA-$8.42M
EPS-$0.17
Financial Health
Debt-to-Equity-5.4%
Free Cash Flow Yield-12.97%
Growth & Risk
EPS 5Y CAGR+375.62%
Beta (5Y)0.84
Sharpe Ratio-0.60